New drug therapies have just become available for the rare disease Idiopathic Thrombocytopenic Purpura or ITP. Join our guest Dr. David J. Kuter, director of hematology, at Massachusetts General Hospital in Boston to explain the development of romiplostim and other ITP drugs and what clinical impact they are having. Hosted by Dr. Bruce Bloom